Big Pharma Direct

A significant portion of these companies is owned by large institutional investors like Blackrock, Vanguard, and State Street, which collectively hold roughly 20% of the industry.

The sector is dominated by a small group of multinational corporations. Big Pharma

"Big Pharma" refers to the world's largest publicly traded pharmaceutical companies. As of late 2025, the industry is navigating significant regulatory changes, particularly in the United States, where the Trump administration has been pressuring major manufacturers to lower prescription costs through "Most-Favored-Nation" (MFN) pricing. Market Leaders and Ownership A significant portion of these companies is owned